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The ongoing coronavirus disease 2019 (COVID-19) 
pandemic, caused by severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), is still spreading across the 
world, infecting several millions of people and causing 
over a million deaths to-date (1). COVID-19 is the third 
coronavirus outbreak that has affected humanity during 
the past two decades, preceded by severe acute respiratory 
syndrome (SARS) in 2002–2003 and Middle-East 
respiratory syndrome (MERS) in 2012 (2). As with all other 
coronaviruses, SARS-CoV-2 is an enveloped virus with 
positive-sense, single-stranded RNA genome, encoding 
four leading structural proteins which are known as Spike 
[S; containing the receptor-binding domain (RBD) through 
which the virus binds to its natural receptors at the surface 
of host cells], the envelope protein (E), the membrane 
protein (M) and the nucleocapsid protein (N) (3).
There is an ongoing discussion, which often fuels fierce 
debates, about the real origin of SARS-CoV-2 (4). We 
personally proffer that scientific debate as to whether this 
“new” coronavirus has been created, or reengineered, within 
a research or clinical laboratory in Wuhan or elsewhere all 
around the world is virtually meaningless. Nonetheless, 
the mysterious SARS-CoV-2 origin is now arguably used 
by many scientists and policymakers as a form of political 
rhetoric, for the poorly hidden purpose of destabilizing 
economic and geopolitical relationships (5). Establishing 
whether SARS-CoV-2 is humanmade or not seems virtually 
impossible, unless someone were to openly admit that the 
virus has been entirely fabricated, modified or has leaked 
from a laboratory.
Leaving political speculations aside from real science, 
several lines of evidence garnered since the beginning of this 
pandemic now allow to credibly pinpoint that SARS-CoV-2 
has a “zoonotic” animal origin, a conclusion supported by a 
deep analysis of the genome and evolutionary history of this 
virus. A bat is indeed the original source of SARS-CoV-2, as 
well as of many other life-threatening viruses such as Ebola, 
rabies, Influenza A and so forth. A phylogenetic analysis 
with structural modeling of spike protein has revealed 
that this moiety has a 97% sequence identity with that of 
another bat coronavirus (i.e., BatCov-RaTG13), and also 
shares a 97% sequence identity in the RBD with a pangolin 
coronavirus [i.e., 2019 Guandong (GD) Pangolin] (6). This 
may suggest that SARS-CoV-2 has probably originated 
from recombination of these two animal coronaviruses in 
an intermediate host (e.g., pangolin?), and has then infected 
humans as a consequence of spillover. Notably, SARS-
CoV-2 also shares 76% structural homology with SARS-
CoV-1, the virus which caused the SARS outbreak nearly 
20 years ago. However, the structural homology between 
these two viruses in the RBD is limited, lower than 50%, 
which would perhaps explain the different biological and 
clinical features between SARS and COVID-19. One of 
the most intriguing aspects in SARS-CoV-2 biology, is 
why this and the two previous similar coronaviruses that 
caused SARS and MERS display such high virulence and 
pathogenicity compared to other coronaviruses which 
only cause a common cold. A possible explanation has 
been given in the seminal work of Gussow et al. (7), in 
which it was demonstrated that these three coronaviruses 
have undergone a convergent trend in their evolution, 
characterized by enhancement of nuclear localization 
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signal in their N protein, which contributes to modify 
their subcellular localization, combined with important 
insertions in the spike protein, which may ultimately 
facilitate and amplify their binding to host cell receptors. 
Another intriguing aspect in SARS-CoV-2 biology is that 
this virus undergoes considerable intra- and inter-human 
recombination. There is little doubt that SARS-CoV-2 has 
undergone many mutations since its first appearance in 
China and will continue to do so while it remains among us. 
This is not surprising since viruses which directly encode 
their genome in RNA, including HIV and influenza along 
with SARS-CoV-2, seems to insert mutations in their 
RNA rapidly. This occurs because these microorganisms 
reproduce inside their hosts, where enzymes copying 
RNA are more vulnerable to errors (8). A comprehensive 
description of SARS-CoV-2 phylogeny is available on the 
website of the Global Initiative on Sharing All Influenza 
Data (GISAID), which lists the huge complexity of the 
recombinant events that the virus has undergone thus far (a 
temporal resolution analysis is consistent with nucleotide 
replacement rate of around 8×104 yearly subs per site, 
giving rise to as many as 4,771 genomes sampled to date) (9). 
Interestingly, a study published by Tiwari and Mishra 
concluded that nonsynonymous substitutions generated not 
less than 57 amino acid changes distributed over different 
viral proteins, with maximum genetic variation observed 
in the region encoding for the spike protein, which may 
then be reflected by import structural and functional 
heterogeneity when the spike protein interacts with host 
cell receptors (10). The leading source of these mutations 
is hence human recombination. In the interesting study 
of Shen and colleagues, the median number of intra-host 
SARS-CoV-2 variants was found to range between 1 and 4 
in infected patients, but cumulatively spanning over a very 
vast array, between 0 and 51 (11). Rather understandably, 
this intra-individual recombination process may have 
considerable impacts on virulence, infectivity, pathogenicity 
and transmissibility of the virus.
Conspiracy theories on the origin and spread of 
COVID-19 have ranged from the virus being a lab-
designed bioweapon or 5G cell phone towers which 
accelerate the spread of the virus or a meteor which carried 
the virus to planet Earth when it struck northeastern China 
in October (12). Such theories have also been rapidly spread 
around the world via social media. Nonetheless, the current 
biological evidence would lead us to generate a possible 
Figure 1 Possible origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19, coronavirus disease 2019; SARS-
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theory on the origin and spillover of SARS-CoV-2, as 
shown in Figure 1. Briefly, the virus has likely originated 
from a bat coronavirus, probably BatCoV-RaTG13, which 
has been transmitted to another intermediate animal, 
maybe a pangolin, where the ancestral virus has undergone 
primary intra-animal recombination. This new virus (e.g., 
2019 GX/GD Pangolin) was likely then transmitted to the 
first human index case, where it then became the SARS-
CoV-2 that originated in the first local outbreak. Failure 
to timely recognize the first diffusion of the virus within 
a likely circumscribed human niche has enabled further 
intra-human recombination processes, which then finally 
generated the highly virulent pathogen that is causing the 
ongoing pandemic outbreak. This theory is inherently 
supported by data showing that the virus has circulated at 
lower virulence much earlier before its first identification 
in Wuhan. For example, evidence from environmental 
monitoring suggests that the virus started to circulate in 
Italy as early as December 2019, while the much larger 
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